Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Molecular Pharmacology|November 30, 2011
PPAR-γ agonists in polycystic kidney disease with frequent development of cardiovascular disordersShizuko Nagao, Tamio Yamaguchi
Experimental Animals|October 26, 2012
Animal models for human polycystic kidney diseaseShizuko Nagao, Masanori Kugita, Daisuke Yoshihara, et al.
American Journal of Physiology. Renal Physiology|September 3, 2010
Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cellsTamio Yamaguchi, Gail A Reif, James P Calvet, et al.
Plos One|March 15, 2019
Increased salt intake does not worsen the progression of renal cystic disease in high water-loaded PCK ratsShizuko Nagao, Masanori Kugita, Kanako Kumamoto, et al.
Journal of the American Society of Nephrology : JASN|December 2, 2005
Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cellsTamio Yamaguchi, Scott J Hempson, Gail A Reif, et al.
Molecular Nutrition & Food Research|October 31, 2013
Renal cyclooxygenase and lipoxygenase products are altered in polycystic kidneys and by dietary soy protein and fish oil treatment in the Han:SPRD-Cy ratNaser H M Ibrahim, Yong Jia, Jessay G Devassy, et al.
Pageof 4